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Background
Relapse prevention strategies based on monitoring of early
warning signs (EWS) are advocated for the management of
psychosis. However, there has been a lack of research exploring
how staff, carers and patientsmake sense of the utility of EWS, or
how these are implemented in context.
Aims
To develop a multiperspective theory of how EWS are under-
stood and used, which is grounded in the experiences of mental
health staff, carers and patients.
Method
Twenty-five focus groups were held across Glasgow and
Melbourne (EMPOWER Trial, ISRCTN: 99559262). Participants
comprised 88 mental health staff, 21 patients and 40 carers from
UK and Australia (total n = 149). Data were analysed using con-
structivist grounded theory.
Results
All participants appeared to recognise EWS and acknowledged
the importance of responding to EWS to support relapse pre-
vention. However, recognition of and acting on EWS were con-
structed in a context of uncertainty, which appeared linked to
risk appraisals that were dependent on distinct stakeholder roles
and experiences. Within current relapsemanagement, a process
of weighted decision-making (where one factor was seen as
more important than others) described how stakeholders
weighed up the risks and consequences of relapse alongside the
risks and consequences of intervention and help-seeking.
Conclusions
Mental health staff, carers and patients speak about using EWS
within a weighted decision-making process, which is acted out in
the context of relationships that exist in current relapse man-
agement, rather than an objective response to specific signs and
symptoms.
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Relapse influences the long-term course of psychosis with rates fol-
lowing a first episode accumulating to 54% at 3 years1 and 80% at 5
years.2 The economic costs of treating relapse are significant.3
Furthermore, relapse increases psychological distress and demoral-
isation in patients4 and disrupts important interpersonal relation-
ships such as those with carers.5 Lack of acceptance of treatment
and unplanned discontinuation of antipsychotics are predictors of
relapse1 reflecting poorer engagement with mental health staff.6
One way of addressing risk of relapse is monitoring early
warning signs (EWS). EWS monitoring is well established for the
detection of relapse, but evidence for routine implementation is
poor.7 This may in part be because of the relatively poor sensitivity
of formal EWS monitoring (median sensitivity 61%)8 and fear of
relapse9 leading to avoidance of help-seeking.4 Lack of meaningful
relationships between patients and mental health staff prevents
implementation of crisis care plans and is a missed opportunity
for shared decision-making.10 Therefore, successful implementa-
tion of early signs monitoring to detect and prevent relapse not
only rests on being able to accurately predict relapse, but also on
the quality of interpersonal interactions, communication and
shared decision-making, including with families and carers.11
Study aims
The EMPOWER trial was simultaneously conducted in both the UK
and Australia. The primary aim of this study was to develop a
multiperspective theory of how EWS are utilised by patients, staff
and carers to inform the future implementation of a clinical trial
of digital technology for relapse detection and prevention
(EMPOWER Trial, ISRCTN: 99559262). The selection of research
questions followed the Medical Research Council12 framework for
developing and evaluating complex interventions.
Method
Design
A qualitative focus group design was chosen to gain insight into parti-
cipants’ perspectives, experiences and expectations.13 Using focus
groups enabled respondents to interact with and respond to the ideas
and comments of other participants.14 Following best practice guide-
lines,12 we used a theoretical framework to guide our focus group sched-
ule. An interview schedule was informed by normalisation process
theory (an implementation theory that helps model the attitudes, beha-
viours and reflections that affect the integration of new complex inter-
ventions into routine care)15 was developed to explore stakeholders’
expectations. We planned to use normalisation process theory to
explore how mental health staff, carers and patients made sense of
EWS, how they engaged with them, the actions they took in relation
to EWS and how effective they thought EWSwere inmanaging relapse.
Sampling and recruitment
Staff who support people with psychosis were recruited from com-
munity mental health services (CMHS) in Glasgow, UK and* See the Acknowledgements for members of the research group.
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Melbourne, Australia. Staff were invited to take part through the
research team making contact with clinical team leaders in all eli-
gible CMHS within both health boards. Patients were recruited to
take part in focus groups through a direct approach by mental
health staff and posters placed in support organisations for people
affected by mental health problems. Patient-participants were eli-
gible if they were in contact with a local CMHS; had experienced
a relapse in the past 2 years; had a diagnosis of a psychosis spectrum
condition and were able to provide informed consent.
Self-identified carers for people with psychosis were recruited by
the research team advertising through posters and word of mouth in
mental health services and support groups. Participants included 88
mental health staff, either working in the National Health Service in
the UK (n = 54, nine focus groups) and NorthWestern Mental
Health service in Australia (n = 34, five focus groups). Twenty-one
patients were recruited from local mental health services in the UK
(n = 5, three focus groups) and Australia (n = 16, four focus
groups) and 40 carers from UK (n = 20, two focus groups) and
Australia (n = 20, three focus groups). To maximise participant ano-
nymity, we did not collect any demographic data beyond whether the
participant was a carer, patient or mental health clinician.
Procedure
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. All procedures
involving patients were approved by the West of Scotland (REC/
16/WS/0042) and Melbourne Health (REC/15/MH/344) Ethics
Committees. Written informed consent was obtained from all par-
ticipants. Carers and patients received £20/$40 and participated in
private rooms within mental health support organisations. Staff
received no financial reimbursement and participated in their place
of work during working hours. Following a short presentation
about EMPOWER that covered trial rationale, design and key
aspects of the intervention, 25 focus groups were conducted locally
following the topic guide. Focus groups were conducted by the
authors A.I.G., H.J.M., J.F. and J.G. (clinical psychologists), A.C., M.L.
and S.A. (research assistants) and S.B. (trial manager), who are all
trained in qualitative methods, between 20 July 2016 to 6 September
2017. Both UK and Australian teams met remotely around once a
week via teleconference to discuss the study. Focus group length
ranged from 57 min to 2 h 9 min. The focus groups were audio
recorded and then transcribed verbatim with transcripts stored on a
secure server. NVIVO software was used16 to perform analysis.
Analysis
Constructivist grounded theory assumes that the phenomenon in
question is interpersonally constructed and context dependent.17
The analysis followed the constructivist grounded theory approach
as outlined by Charmaz.17 Our philosophical stance was influenced
by structural symbolic interactionism, which posits that context is
closely linked to how social or organisational roles of each stake-
holder influences their daily life.18 For example, being a mental
health professional comes with a set of normative expectations
regarding the nature of their mental health expertise, expected
actions and role-driven behaviours.10 This was considered import-
ant as different stakeholders may have different perspectives on
psychosis management.19 Constructivist grounded theory posits17
that themes do not emerge from the data but are constructed as
part of a reflexive analytic process. Therefore, themes will be
reported as such.
Focus group transcripts were coded line-by-line by primary
coder S.A. (a PhD student researching digital interventions for
psychosis) through an inductive process, developing open codes
that summarised the transcripts. Categories were then formed by
repeatedly comparing open codes to see if these could be linked
together. During the final theoretical coding stage, data from all
three groups were repeatedly compared to see if categories could
be linked together as a higher order unifying or overarching
theme, or if there were differences between groups.
There is no prescriptive method for ensuring quality in qualita-
tive analysis,20 therefore, reporting of results followed good practice
guidelines.21 For example, we made our philosophical position
(constructivism) clear for the reader and our intentions behind
the study (exploring existing context in advance of implementing
an intervention) transparent. Furthermore, S.A. kept reflexive
memos throughout the study, which recorded how the influence
of researcher characteristics and experiences may have shaped ana-
lysis. Analysis was triangulated by discussion with academic clini-
cians (A.I.G. and H.J.M.). Only data relevant to the aims of study
(understanding how EWS management is currently sustained in
context by three stake-holding groups) were included in this
paper. Member checking (where participants check over themes
proposed by the researcher as an interpretation validity check)22
was not undertaken. The quotes chosen are illustrative of the
most common constructions within the data. See Appendix 1 for
an overview of the overarching themes and subthemes.
Results
Weighted decision-making
We constructed an overarching theme termed weighted decision-
making, reflecting a process acted out by different stakeholders’
responses to the uncertain context of EWS. Throughout all
groups, weighted decision-making was constructed as a process
that emerged from interactions between patients, staff and carers
(if a person had one). Weighted decision-making was strongly
linked to risk appraisal, with each group having their own distinct-
ive (and sometimes shared) experiences of the harms and benefits of
acting on EWS as a strategy to prevent relapse. This overarching
theory comprised four key themes: the apparent consensus
around EWS; meaning and consequences of EWS identification;
experience as expertise; and EWS decision-making processes, each
of which is now described and explained in turn.
The apparent consensus around EWS
There was consensus across stakeholders that EWS were experi-
ences or behaviours that are taken to indicate risk of relapse, and
that identifying EWS was a potentially useful way to understand
changes in well-being and to allow for early intervention. Patients
described a variety of personal experiences labelled as EWS. Their
descriptions suggested that EWS function as a barometer for recog-
nising changes in well-being.
Researcher 2: ‘And how helpful would you say it is to kind of
monitor early warning signs?’
Participant 2: ‘It’s important. It’s important for your well-
being. See how you feel the next morning. See how your
health is, your mindset. It’s very important.’ (Patient group
6, Australia)
Carers reflected on the function of EWS as a means to identify
and act in order to avert mental health crises. Carers valued moni-
toring early signs as a basis for preventing a potential relapse.
‘You can stop it from escalating and into a full-blown episode.
You can see when it’s coming on. They can increase the
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medication or encourage them to see the doctor or something
like that. There’s lots of things you can do. But, you know, once
they get too sick, then it gets more difficult, they get more sus-
picious.’ (Participant 6, Carer group 4, Australia)
Mental health staff reported that EWS offered an indicator that
things were starting to break down for a patient and signalled when
staff believed that intervention was needed. Staff appeared to believe
that if EWS were noticed and acted upon, then there was an oppor-
tunity that relapses could be managed.
‘I think it’s their behaviours; you know, if there’s a sudden
change or you know, that if you’ve done your relapse preven-
tion and they have identified relapse triggers, then the person’s
starting to do them.’ (Participant 1, Staff centre 7, UK)
Meaning and consequences of EWS identification
Although there was broad agreement by stakeholders on the func-
tion of EWS as a tool to detect and ameliorate risk of relapse,
each group articulated distinctive expectations regarding the pos-
sible sequence of events following the recognition of EWS. These
distinctive expectations were closely linked to the meanings of
relapse for each stakeholder group.
Carers generally valued EWS, however, our analysis suggested
that the benefits of identifying EWS came with the possible conse-
quence that a loved one could feel harmed from subsequent inter-
ventions. Many carers described traumatic experiences connected
to relapse (such as an admission to hospital) and their reluctance
to involve services. Although carers recognised the value of recog-
nising and acting on EWS, they also feared the potential impact
of acting on these in terms of the impact on their relationship
with their loved one or the impact of experiences such as being
put in hospital upon their loved ones.
‘I don’t want to do anything that’s going to push her, you know
because there’s already part of that whole sectioning process,
and that is a huge thing to go through that in a family
dynamic.’ (Participant 5, Carer group 2, UK)
Many patients spoke in great detail about the personal distress
caused by experiences of psychosis in the context of a relapse.
Such experiences were commonly described by patients, which sug-
gested that relapse represented a threat to personal well-being.
Patients often feared that relapse would also be associated with a
series of consequences including the expectation that letting
others know about EWS could result in a potential threat to their
autonomy such as being made to go to hospital.
‘Sometimes you don’t want to say anything in case you get a
negative response. I don’t want to go back to the hospital.’
(Participant 2, Patient group 2, UK)
A sense of relapse being somewhat inevitable was observed
across the staff focus groups.
Staff recognised that identification of EWS and relapse preven-
tion was an expected part of their role as clinicians. Therefore, the
importance of EWS monitoring as a basis for minimising the
impact of relapse was generally seen as an essential part of staff
responsibilities. However, staff were open to the possibility that
foregrounding relapse prevention in such a risk averse manner
might not accord with how patients want to manage their own
well-being.
‘You are not going to prevent relapse – relapse is always going
to be there. On some sort of scale, even people who are well
have momentary relapses.’ (Participant 1, Staff centre 1, UK)
‘I reckon like this is a massive generalisation but I think we
[staff] are probably more conservative in the sense that we
would probably do more to prevent a relapse but sometimes
maybe you can see the consumers’ situation where they will
entertain a few more risks, you know – around the
potential for relapse if they think that some other benefit like
they get to do something else in their life – whereas we are
probably a bit more conservative.’ (Participant 5, Staff centre
12, Australia)
Experience as expertise
The nature of risk appraisals linked to EWS expressed by different
stakeholders appeared distinctive and reflected contrasting con-
cerns and different types of knowledge and experience. Patients
described a dual process of making sense of their own experiences
and of how others (particularly mental health staff) would interpret
their experiences. This was heavily influenced by their own risk
assessment: acknowledging the personal threat a relapse posed
and then assessing the external threat of how other people would
respond. Patients embedded their appraisals in their previous
experiences when appraising EWS disclosure risk. In addition,
patients perceived that their experiential expertise in appraising
the risk of EWS could be downplayed by staff.
‘We hate hospital, but we also want to be as honest as we can
and often we want to be able to manage our own symptoms
too. We don’t want to be medicated up to our eyeballs.’
(Participant 1, Patient group 5, Australia)
For carers, their expertise in assessing the EWS risk in this
context came from knowledge gained through their close contacts.
Carers often described themselves as being able to successfully con-
textualise the risk of EWS through knowing their loved one.
‘my sister’s now, what, fifty-two, so she was diagnosed when
she was twenty-one. And why I say I’m her carer, is I recognise
the signs.’ (Participant 3, Carer group 4, Australia)
Carers also reported frustration that staff sometimes did not
value carer assessment of the risk posed by EWS. Many carers
believed that staff did not recognise the value of their knowledge,
experience and expertise.
‘Well I don’t like the fact that I get told “your son is doing really
really well, really really really” and I phone up and say “I’m
really concerned”.’ (Participant 2, Carer group 2, UK)
Staff reflected on their expertise in recognising and acting upon
EWS. This appeared formalised in professional mental health guide-
lines and policies reflecting both their broader clinical expertise and
also their more intimate knowledge of a patient. They reflected on
the uncertainty and complexity of acting in response to early signs
and the importance of being able to personalise their response to EWS.
Participant 2: ‘we’re kind of conscious that we’ll be trying to fit
it to the individual. Obviously, people’s experiences with some-
thing might work better for some people. But I’d imagine it’d
be pretty similar with a few provisions maybe.’
Participant 3: ‘There an Integrated Care Pathway and kind of
all those guidelines.’ (Staff centre 7, UK)
‘you can only do what you can do as a key clinician in terms
of you know those policy procedures we’ve just discussed
and there’s a whole other gamut of influences that might
impact on a consumer that are out of our scope to influence
I guess. So, um, I think that’s… it’s tricky and every consumer
is completely different and has different warning signs
based on potentially their diagnosis or potential harm so
it’s yeah. I guess when you are actually addressing those
EWS – it really just depends.’ (Participant 1, Staff centre 12,
Australia)
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Staff valued their individualised knowledge built up through
their relationships with patients. In the absence of this, staff then
placed their expertise in a team context, utilising colleagues’ insights
and case notes for developing and evidencing their risk assessment
of EWS. The actions reported by staff implied that broader staff
knowledge was regarded as a reliable and trustworthy source of
information.
‘I’m just thinking, what would I do in a crisis phone call? So, I
would look at notes, try and speak to the person. I would go to
that team and say, “who knows this person?” So, I would be
trying the collective formal and informal consciousness of
the team. Because I don’t know all the answers.’ (Participant
1, Staff centre 3, UK)
If staff recognised behaviours they believed were EWS (without
a patient reporting EWS experiences to staff) then this appeared to
be taken as a ‘lack of insight’ and an indicator of increased risk of a
relapse occurring. This commonly resulted in staff believing they
needed to take ownership of clinical risk assessment, which
appeared to impede sharing decision-making.
‘There’s StayingWell plans and stuff like that. People, we get to
sit down and talk about that side, and what happens when they
become unwell and things like that. But I’ve never really had a
patient phone me saying “listen, I’ve referred back to this plan,
and I’m starting to get some of these symptoms”. You know.
It’s usually way past that and you pick it up yourself because
they just don’t have the insight to notice.’ (Participant 4,
Staff centre 9, UK)
EWS decision-making processes
For staff, intervention decisions were based upon a risk gradient. For
example, if EWS were perceived to be low risk (in this context – a
threat to patient well-being but which could not be ruled out as a
false positive), then staff interventions focused on helping the
patient manage their experiences. If the risk was perceived to be
greater (in this context risk being severe detriment to patient well-
being and more indicative of a relapse event), then the staff role
shifted from relapse prevention to relapse management where inter-
vention options included enforced treatment.
‘there will be steps to take to ensure the consumer isn’t getting
to the point where they are really unwell – being able to prevent
that pretty much – most of it, all of it, getting in contact, you
know. Getting input from the medical team – even using
legal measures such as a temporary community treatment
order or a system those things…, yeah. It’s different for every-
body, but there are ways where we can really try and manage
someone.’ (Participant 3, Staff centre 12, Australia)
Decisions were contextualised by constraints on mental health
service provision particularly responsibilities for large case-loads.
Staff reported having to invest more time with patients who they
perceived to have the greatest likelihood of experiencing relapse
and feeling dissatisfied with routine practice. This was felt to have
an impact on the quality of working relationships and the ability
to respond proactively to EWS.
‘What we find difficult as nurses is massive caseloads and
trying to maintain quality of care trying to make sure things
like that are all up to date so it’s hard it’s nice in theory to
say “oh this is what happens and this always happens” but
we’d love it to always happen but sometimes we don’t have
time to do that and it’s there chasing you every day and
you’re thinking oh my god. Best practice. Core standard.
Every patient would have that, but reality is we don’t often
get the time to do it for everybody.’ (Participant 1, Staff
centre 1, UK)
Decision-making for patients was constructed as a process of
weighing up the personal benefits and risks of disclosure of EWS.
The expectation that other people would overreact was frequently
described as a barrier to help-seeking. Patients described how
their decision-making processes were shaped by these sources of
uncertainty associated with disclosure.
‘I get a bit scared to tell people about the early signs. Because
you don’t want people to blow it out of proportion and then
they’re staring at you and watching your every move. I don’t
like that; I like my privacy. And so I like…I don’t know.’
(Participant 1, Patient group 1, UK)
Some patients spoke about times when staff responses did not
result in an expected level of support to help them manage distress.
This meant that patients were left tomanage distress alone, left them
feeling dejected and less incentivised towards future help-seeking.
‘it’s really hard to get to help when you’re in psychosis, people
don’t want to take on the responsibility of helping you and it’s
not always very easy to ring triage and then get the appropriate
response that you want.’ (Participant 3, Patient group 4,
Australia)
The struggles expressed by patients with respect to the personal
risks of help-seeking were also reflected by carers who did not
believe staff were likely to have access to all the relevant information
needed for optimal decision-making. Carers reported that they
could provide context and detail especially in response to non-
disclosure by patients.
Participant 2: ‘We often have the feeling that we want to ring
them up and say “but all this is going on, and you probably
don’t know about it” or “she’s probably not telling you the
history of what’s happened beforehand”.’
Participant 4: ‘Yeah. That’s why it’s really important to say
“This is what’s really going on”.’ (Carer group 4, Australia)
Discussion
This study aimed to create a multiperspective theoretical account of
how EWS are experienced and acted out in routine practice. Relapse
into psychosis has major ramifications for everyone involved.
However, to the best of our knowledge, the context in which EWS
are identified and acted on has not previously been described in
detail from the perspectives of mental health staff, patients and
carers. Self-management interventions for severe mental illness
have been reported to generally improve mental health outcomes
but the evidence is mixed for relapse prevention.23 However, this
was noted to be in contrast to a previous meta-analyses that
focused on schizophrenia24 where self-management interventions
(including EWS monitoring) were associated with a significant
reduction in relapse events. A call has been made for research
that is focused on how to understand and overcome barriers to
the implementation of self-management interventions.23 This
study represents the first large-scale qualitative investigation of
how EWS are understood and experienced by staff, patients and
carers across two geographically distinct healthcare systems.
Weighted decision-making
Relapse was described as a negative event throughout the focus
groups with no stakeholders in these specific focus groups describ-
ing relapse as potentially positive, which may imply relapse is
perceived as a persistent and ongoing threat. All groups seemed to
recognise EWS and emphasised their possible value for relapse pre-
vention. However, recognition of and acting on EWS were
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constructed in a context of uncertainty – in line with previous
research from early intervention populations.25 Within current
relapse management, a weighted decision-making process described
how stakeholders weighed up role-congruent26 consequences of
relapse alongside role-congruent risks and consequences of inter-
vention and help-seeking. A key finding from our qualitative ana-
lysis was that responses to EWS appeared linked to risk appraisal
and there are differences in how risk is appraised by staff, carers
and patients that are closely related to participants’ previous experi-
ences and for staff, their professional role.
Similar to findings from previous research,27 carers seemed con-
cerned about relapse. Carers weighed the risk posed by EWS of a
potential relapse within the context of their close personal knowl-
edge about the person they care for. Carers described wanting to
provide supplementary or countervailing information to predict
relapse and improve clinical decision-making. However, they
reported that their expertise and EWS assessment were often dis-
missed and devalued by staff. These findings resonate with previous
research showing that carers believe they have excellent knowledge
of the EWS of relapse from close relationships, but do not feel staff
value their knowledge as clinically relevant.28 Furthermore, carers
disclosing EWS to staff may come with a risk of undermining rela-
tionships with patients.
The uncertainty about the degree to which staff may respond
was a key factor, which weighed into patients’ decisions about
help-seeking. This was in contrast to staff expectations that failure
to help-seek arose from a lack of insight. For some patients, the
potential losses arising from seeking help (such as loss of autonomy)
outweighed the potential gains in terms of preventing a deterior-
ation in well-being – echoing previous work by Sibitz et al.29
However, some patients also spoke about not receiving adequate
support from mental health services when they were struggling,
despite promptly reporting EWS.
Broader contextual factors influenced decision-making. Staff
spoke about EWS as an important opportunity to prevent or min-
imise relapse, but felt that in reality they were constrained by high
case-loads and inadequate resources – leading to an emphasis on
crisis interventions at the cost of developing close working relation-
ships, critical to anticipating and supporting relapse prevention.
Lower staff continuity has been linked to worse clinical outcomes
in schizophrenia,30 and inadequate staffing appears linked to
increased use of restrictive practices over de-escalation techniques,
because these are considered more time efficient in poorly staffed
wards.31 Research on clinical decision-making is stated to be diffi-
cult to conduct because of the dynamic environment of applied set-
tings.32 This analysis suggests EWS are utilised within a particularly
dynamic and intersubjective decision-making process, with stake-
holders valuing different outcomes. For example, patients may
value personal autonomy over the clinical stability typically
valued by staff. Although these findings are from qualitative data
and should be interpreted with caution, they may offer a theoretical
basis for exploring applied clinical decision-making further. For
example, discrete choice experiments33 would allow the relative
value of costs and benefits for different stakeholders to be empiric-
ally tested.
Limitations
With qualitative research it is not possible to make comment on the
generalisability of any findings. Furthermore, all participants volun-
teered to take part within focus groups, which raises the possibility
that we may have missed important perspectives from those who
did not participate. Although focus groups allowed for participants
to interact together and discuss topics, it may be the case that some
participants could feel uncomfortable contributing contradictory
viewpoints. Individual interviews may have been more appropriate
for discussing potentially sensitive topics such as EWS.
The real-world clinical context of EWS usage comes from inter-
actions between mental health staff, carers and patients. However,
we spoke to these groups in isolation from each other, which may
have had an impact on the results. Also, although at a conceptual
level we observed no differences in how people understood and
use EWS between Australia and UK, we did not explicitly explore
the way in which the distinctive health systems that contextualise
practice might influence stakeholders’ views and experiences.
Additionally, staff, carer and patient participation were unba-
lanced, with lower numbers of patients participating. Our approach
to recruiting mental health staff enabled us to systematically
approach all local CMHS in our two study sites. However, we
were unable to have such a systematic approach to user and carer
participation and our lower rates of participation reflect this.
Furthermore, it should be acknowledged that many patients live
alone in the community without support from a carer.
Not collecting demographic data was important to better
protect participant anonymity and this was a pragmatic methodo-
logical choice, however, we acknowledge it is a limitation for
readers in interpreting the data.
Implications for mental health practice
Qualitative methods have been found to be helpful in uncovering
‘ruptures in communication’, wherein differences in how doctors
and patients understand medical problems can lead to distress
and dissatisfaction with care.13 In highlighting how mental health
staff, patients and carers described their experiences, it seems
EWS are used within a weighted decision-making process, which
is acted out in the context of relationships, rather than an objective
response to specific signs and symptoms. However, there were
marked differences in how groups spoke about this decision-
making process. Patients and carers reported that staff sometimes
did not appear to value their knowledge about EWS and self-man-
agement. This may be part of a broader issue, where the subjective
experiences of patients and carers are perceived to be less clinically
useful because these are perceived to be at risk of bias.34 These find-
ings echo previous qualitative research examining implementation
of joint crisis care plans, which found that staff prioritised risk
assessment in accordance with their professional roles at the cost
of addressing patients’ priorities for their treatment and care.35
EWS-based intervention development and implementation
may be enhanced by better utilising the knowledge of carers and
patients who bring expertise to shared decision-making. For
example, interventions that gather data from patients and/or
carers may reduce clinical uncertainty by placing EWS in a mean-
ingful context. The sharing of data showing temporal well-being
changes within this weighted decision-making process could influ-
ence interactions with key clinicians and reduce uncertainty about
the potential negative impact of help-seeking (for all groups) by
allowing for predictable alerting of EWS.
Relationships appear to be the context in which weighted deci-
sion-making involving EWS is both acted out and understood.
These results suggest that uncertainty of how others will behave
may create a barrier to early intervention. EWS-based interventions
may be better implemented if they address this uncertainty by pro-
viding a clearer stepped care pathway, for example through a focus
on shared decision-making.36 In order for EWS-based interventions
to be a ‘good fit’ within the context of current relapse management,
interventions should aim to change the interpersonal interrelation-
ship behaviours of staff, patients and carers (where applicable),
rather than targeting a single social actor.
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Appendix 1
Themes
Dominant theme Subthemes
1. 1. Weighted decision-
making
1.1 The apparent consensus around early
warning signs
1.2 Early warning signs decision-making
processes
1.3 Experience as expertise
1.4 Meaning and consequences of early
warning signs identification
References
1 Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG, et al.
Risk factors for relapse following treatment for first episode psychosis: a sys-
tematic review and meta-analysis of longitudinal studies. Schizophr Res
2012; 139: 116–28.
2 Robinson D, Woerner MG, Alvir JMJ, Bilder R, Goldman R, Geisler S, et al.
Predictors of relapse following response from a first episode of schizophrenia
or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241.
3 Pennington M, McCrone P. The cost of relapse in schizophrenia.
Pharmacoeconomics 2017; 35: 921–36.
4 Gumley A, MacBeth A. A trauma based model of relapse in psychosis. In
Trauma and Psychosis: New Directions for Theory and Therapy (eds AP
Morrison and W Larkin): 283–304. Routledge, 2006.
5 Tempier R, Balbuena L, Lepnurm M, Craig TKJ. Perceived emotional support in
remission: results from an 18-month follow-up of patients with early episode
psychosis. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1897–904.
6 Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in
schizophrenia: validity, frequency, predictors, and patients’ perspective 5
years later. Dialogues Clin Neurosci 2010; 12: 393–407.
7 Morriss R, Vinjamuri I, Faizal MA, Bolton CA, McCarthy JP. Training to recognise
the early signs of recurrence in schizophrenia. Cochrane Database Syst Rev
2013; 2:CD005147.
8 Eisner E, Drake R, Barrowclough C. Assessing early signs of relapse in psych-
osis: review and future directions. Clin Psychol Rev 2013; 33: 637–53.
9 Gumley AI, Macbeth A, Reilly JD, O’Grady M, White RG, McLeod H, et al. Fear of
recurrence: results of a randomized trial of relapse detection in schizophrenia.
Br J Clin Psychol 2015; 54: 49–62.
10 Farrelly S, Lester H, Rose D, BirchwoodM,Marshall M,WaheedW, et al. Barriers
to shared decision making in mental health care: qualitative study of the Joint
Crisis Plan for psychosis. Heal Expect 2016; 19: 448–58.
11 Onwumere J, Shiers D, Chew-Graham C. Understanding the needs of carers of
people with psychosis in primary care. Br J Gen Pract 2016; 66: 400–1.
12 Moore G, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process
evaluation of complex interventions: medical research council guidance. BMJ
2015; 350: h1258.
13 Braun V, Clarke V. Novel insights into patients’ life-worlds: the value of qualita-
tive research. Lancet Psychiatry 2019; 6: 720–1.
14 Kruger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research.
Sage publications, 2014.
15 May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al.
Development of a theory of implementation and integration: normalization
process theory. Implement Sci 2009; 4: 1–9.
16 QSR IPL. NVivo qualitative data analysis Software Version 11.1.1. QSR
International Pty Ltd, 2015.
17 Charmaz K. The power of constructivist grounded theory for critical inquiry.
Qual Inq 2017; 23: 34–45.
18 Stryker S. Frommead to a structural symbolic interactionism and beyond.Annu
Rev Sociol 2008; 34: 15–31.
19 Stovell D, Wearden A, Morrison AP, Hutton P. Service users’ experiences of the
treatment decision-making process in psychosis: a phenomenological analysis.
Psychosis 2016; 8: 311–23.
20 Noble H, Smith J. Issues of validity and reliability in qualitative research. Evid
Based Nurs 2015; 18: 34–5.
21 Tong A, Sainsbury P, Craig J. Consolidated criterio for reporting qualitative
research (COREQ): a 32- item checklist for interviews and focus group. Int J
Qual Heal Care 2007; 19: 349–57.
22 Doyle S. Member checking with older women: a framework for negotiating
meaning member checking with older women: a framework for negotiating
meaning. Health Care Women Int 2007; 28: 888–908.
23 Lean M, Fornells-Ambrojo M, Milton A, Lloyd-Evans B, Harrison-Stewart B,
Yesufu-Udechuku A, et al. Self-management interventions for people with
severe mental illness: systematic review and meta-analysis. Br J Psychiatry
2019; 214: 260–8.
24 Zou H, Li Z, Nolan MT, Arthur D, Wang H, Hu L. Self-management education
interventions for persons with schizophrenia: a meta-analysis. Int J Ment
Health Nurs 2013; 22: 256–71.
25 Cabassa LJ, Piscitelli S, Haselden M, Lee RJ, Essock SM, Dixon LB.
Understanding pathways to care of individuals entering a specialized early
intervention service for first-episode psychosis. Psychiatr Serv 2018; 69:
648–56.
26 Stryker S, Burke P. The past, present, and future of an identity theory. Soc
Psychol (Gott) 2000; 63: 284–97.
Allan et al
6
27 Lal S, Malla A, Marandola G, Thériault J, Tibbo P, Manchanda R, et al. ‘Worried
about relapse’: family members’ experiences and perspectives of relapse in
first-episode psychosis. Early Interv Psychiatry 2019; 13: 24–9.
28 Olasoji M,Maude P,McCauley K. Not sick enough: experiences of carers of peo-
ple with mental illness negotiating care for their relatives with mental health
services. J Psychiatr Ment Health Nurs 2017; 24: 403–11.
29 Sibitz I, Scheutz A, Lakeman R, Schrank B, Schaffer M, Amering M. Impact of
coercive measures on life stories: qualitative study. Br J Psychiatry 2011;
199: 239–44.
30 Macdonald A, Adamis D, Craig T, Murray R. Continuity of care and clinical out-
comes in the community for people with severe mental illness. Br J Psychiatry
2019; 214: 273–8.
31 Price O, Baker J, Bee P, Lovell K. The support-control continuum: an investiga-
tion of staff perspectives on factors influencing the success or failure of
de-escalation techniques for the management of violence and aggression in
mental health settings. Int J Nurs Stud 2018; 77: 197–206.
32 Muntean WJ. Nursing Clinical Decision-Making: A Literature Review. National
Council of State Boards of Nursing, 2012 (https://www.ncsbn.org/Clinical_
Judgment_Lit_Review_Executive_Summary.pdf).
33 Ryan M. Discrete choice experiments in health care. BMJ 2004; 328: 360–1.
34 Greenhalgh T, Snow R, Ryan S, Rees S, Salisbury H. Six ‘biases’ against patients
and carers in evidence-based medicine. BMC Med 2015; 13: 200.
35 Farrelly S, Lester H, Rose D, Birchwood M, Marshall M, Waheed W, et al.
Improving therapeutic relationships. Qual Health Res 2015; 25: 1637–47.
36 Slade M. Implementing shared decision making in routine mental health care.
World Psychiatry 2017; 16: 146–53.
Perspectives on early warning signs of relapse in psychosis
7
